“Policies aimed at curbing the opioid epidemic have been issued by nearly all major federal stakeholders this year: the CDC released opioid prescribing guidelines for physicians; the FDA promoted an opioid ‘action plan;’ HHS raised the prescribing cap on buprenorphine; and the Cures Act earmarked $1 billion for state addiction treatment programs. It may be too early to tell, but in this follow-up story, MedPage Today asks whether this assault against the epidemic is starting to have an impact.”
Read more at: http://www.medpagetoday.com/Neurology/GeneralNeurology/62257
Source: MedPageToday.com – December 27, 2016
